Dame Emma Walmsley

The Oxford-trained executive who became the first woman to lead a major global pharmaceutical company and refocused GSK around vaccines and specialty medicines.

By L&I Global Bureau·9 June 2026·8 min read

Emma Walmsley was born in 1969 and trained in classics and modern languages at Oxford before building a 17-year career at L'Oréal across Europe, the United States and Asia. She joined GSK in 2010, led its consumer-healthcare business and was named chief executive of the entire group in 2017 — the first woman to lead a top-tier global pharmaceutical company.

Under her leadership GSK has separated its consumer-healthcare arm into the independently listed Haleon and refocused on a pipeline anchored in vaccines, infectious diseases, HIV, oncology and immunology, with substantial investment in research and development productivity.

Walmsley has become a prominent corporate voice on female participation in senior leadership in the global pharmaceutical industry.

Leadership Philosophy

“Focus is the most underrated strategic asset. Most companies fail not from too few options, but from too many.”

Notable Achievements

01First woman to lead a top-tier global pharmaceutical company
02Led the separation of Haleon as an independent consumer-healthcare company
03Refocused GSK around vaccines and specialty medicines

Editorial note: this profile was drafted by the Leaders & Impact AI editorial system from publicly available information and reviewed for factual integrity by the L&I Global Bureau. The Leadership Impact Score is a proprietary L&I composite index and is updated continuously.

Dame Emma Walmsley

Notable Achievements

More in Pharmaceuticals

Albert Bourla

Pascal Soriot

Lars Fruergaard Jørgensen